Detalhe da pesquisa
1.
CD19/CD22 targeting with cotransduced CAR T cells to prevent antigen-negative relapse after CAR T-cell therapy for B-cell ALL.
Blood
; 143(2): 118-123, 2024 Jan 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37647647
2.
Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies.
Lancet
; 396(10266): 1885-1894, 2020 12 12.
Artigo
Inglês
| MEDLINE | ID: mdl-33308471
3.
Proposed Therapeutic Range of Treosulfan in Reduced Toxicity Pediatric Allogeneic Hematopoietic Stem Cell Transplant Conditioning: Results From a Prospective Trial.
Clin Pharmacol Ther
; 108(2): 264-273, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-31701524
4.
Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR.
Nat Med
; 25(9): 1408-1414, 2019 09.
Artigo
Inglês
| MEDLINE | ID: mdl-31477906
5.
Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells.
Sci Transl Med
; 9(374)2017 01 25.
Artigo
Inglês
| MEDLINE | ID: mdl-28123068